top of page

Cleerly’s James Min talks about heart disease and improving cardiovascular imaging at #HLTH2023

Dr. Min describes how Cleerly’s technology is designed to improve how CT scans are analyzed, and how the company aims to move upstream from symptomatic disease to doing asymptomatic screening as well.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

NYSE_logo_large_no reg_378x197 (1).png

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

bottom of page